Allarity Therapeutics, Inc.
General ticker "ALLR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.2M (TTM average)
Allarity Therapeutics, Inc. follows the US Stock Market performance with the rate: 23.5%.
Estimated limits based on current volatility of 4.8%: low 0.83$, high 0.91$
Factors to consider:
- Total employees count: 9 (+28.6%) as of 2025
- Top business risk factors: Regulatory and compliance, Clinical trial delays, Capital shortage, Labor/talent shortage/retention, Market acceptance
Short-term ALLR quotes
Long-term ALLR plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.32MM |
| Operating Expenses | $17.13MM | $27.24MM | $12.93MM |
| Operating Income | $-17.13MM | $-27.24MM | $-12.61MM |
| Non-Operating Income | $5.31MM | $2.35MM | $1.37MM |
| Interest Expense | $0.50MM | $0.65MM | $0.18MM |
| R&D Expense | $7.10MM | $6.10MM | $6.60MM |
| Income(Loss) | $-11.82MM | $-24.90MM | $-11.23MM |
| Taxes | $0.08MM | $-0.38MM | $0.00MM |
| Net Income(Loss)* | $-11.90MM | $-24.52MM | $-11.23MM |
| Stockholders Equity | $-2.75MM | $11.81MM | $9.83MM |
| Assets | $11.86MM | $22.65MM | $18.26MM |
| Operating Cash Flow | $-12.74MM | $-17.35MM | $-14.82MM |
| Capital expenditure | $0.00MM | $0.30MM | $0.01MM |
| Investing Cash Flow | $0.00MM | $-0.30MM | $-0.01MM |
| Financing Cash Flow | $10.99MM | $36.79MM | $10.65MM |
| Earnings Per Share** | $-3.59 | $-15.26 | $-0.78 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.